ConMed’s Recovery Blunted by Slow Capital Sales

ConMed reported 3Q20 orthopedic revenue of USD $102.2 million, -7.4% vs. 3Q19. While the company's sports medicine procedure volumes improved sequentially, capital sales remain slow and experienced double-digit declines in the quarter. ConMed leadership believes that its orthopedic backlog of procedures is now cleared, and new procedures have...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us